INOGEN, INC. Revenue, Net (Deprecated 2018-01-31)
INOGEN, INC. (INGN) reported Revenue, Net (Deprecated 2018-01-31) of $73.58 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-30.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-04-30
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $73.58M, a 60.08% increase year-over-year.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $58.35M, a 36.96% increase year-over-year.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $63.14M, a 33.83% increase year-over-year.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $58.04M, a 27.34% increase year-over-year.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $225.49M, a 34.09% increase from fiscal 2016.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $168.17M, a 48.00% increase from fiscal 2015.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $113.63M, a 55.45% increase from fiscal 2014.
- INOGEN, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $73.10M, a 62.78% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $73.58M 10-Q · filed 2018-04-30 | $131.94M derived: sum of 2 quarters · filed 2018-04-30 | $195.07M derived: sum of 3 quarters · filed 2018-04-30 | $253.11M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-12-31 | $58.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $121.49M derived: sum of 2 quarters · filed 2018-02-27 | $179.53M derived: sum of 3 quarters · filed 2018-02-27 | $225.49M 10-K · filed 2018-02-27 |
| 2017-09-30 | $63.14M 10-Q · filed 2017-11-07 | $121.17M derived: sum of 2 quarters · filed 2017-11-07 | $167.14M 10-Q · filed 2017-11-07 | $209.75M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-06-30 | $58.04M 10-Q · filed 2017-08-03 | $104.00M 10-Q · filed 2017-08-03 | $146.61M derived: sum of 3 quarters · filed 2018-04-30 | $193.78M derived: sum of 4 quarters · filed 2018-04-30 |
| 2017-03-31 | $45.97M 10-Q · filed 2018-04-30 | $88.57M derived: sum of 2 quarters · filed 2018-04-30 | $135.75M derived: sum of 3 quarters · filed 2018-04-30 | $181.32M derived: sum of 4 quarters · filed 2018-04-30 |
| 2016-12-31 | $42.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $89.78M derived: sum of 2 quarters · filed 2018-02-27 | $135.36M derived: sum of 3 quarters · filed 2018-02-27 | $168.17M 10-K · filed 2018-02-27 |
| 2016-09-30 | $47.18M 10-Q · filed 2017-11-07 | $92.75M derived: sum of 2 quarters · filed 2017-11-07 | $125.57M 10-Q · filed 2017-11-07 | $154.51M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $45.58M 10-Q · filed 2017-08-03 | $78.39M 10-Q · filed 2017-08-03 | $107.33M derived: sum of 3 quarters · filed 2018-02-27 | $136.58M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $32.81M 10-Q · filed 2017-05-09 | $61.75M derived: sum of 2 quarters · filed 2018-02-27 | $91.00M derived: sum of 3 quarters · filed 2018-02-27 | $123.39M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $28.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $58.19M derived: sum of 2 quarters · filed 2018-02-27 | $90.58M derived: sum of 3 quarters · filed 2018-02-27 | $113.63M 10-K · filed 2018-02-27 |
| 2015-09-30 | $29.25M 10-Q · filed 2016-11-03 | $61.63M derived: sum of 2 quarters · filed 2016-11-03 | $84.68M 10-Q · filed 2016-11-03 | $103.03M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $32.38M 10-Q · filed 2016-08-04 | $55.43M 10-Q · filed 2016-08-04 | $73.78M derived: sum of 3 quarters · filed 2017-02-28 | $93.21M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $23.05M 10-Q · filed 2016-05-09 | $41.40M derived: sum of 2 quarters · filed 2017-02-28 | $60.82M derived: sum of 3 quarters · filed 2017-02-28 | $81.29M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $18.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $37.77M derived: sum of 2 quarters · filed 2017-02-28 | $58.24M derived: sum of 3 quarters · filed 2017-02-28 | $73.10M 10-K · filed 2017-02-28 |
| 2014-09-30 | $19.43M 10-Q · filed 2015-11-10 | $39.89M derived: sum of 2 quarters · filed 2015-11-10 | $54.75M 10-Q · filed 2015-11-10 | $65.87M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $20.46M 10-Q · filed 2015-08-11 | $35.32M 10-Q · filed 2015-08-11 | $46.45M derived: sum of 3 quarters · filed 2016-03-14 | $58.58M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $14.86M 10-Q · filed 2015-05-12 | $25.98M derived: sum of 2 quarters · filed 2016-03-14 | $38.12M derived: sum of 3 quarters · filed 2016-03-14 | $50.87M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $23.26M derived: sum of 2 quarters · filed 2016-03-14 | $36.01M derived: sum of 3 quarters · filed 2016-03-14 | $44.91M 10-K · filed 2016-03-14 |
| 2013-09-30 | $12.13M 10-Q · filed 2014-11-12 | $24.89M derived: sum of 2 quarters · filed 2014-11-12 | $33.78M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $12.75M 10-Q · filed 2014-08-12 | $21.65M 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $8.89M 10-Q · filed 2014-05-13 | |||
| 2012-12-31 | $28.70M 10-K · filed 2015-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |